<DOC>
	<DOCNO>NCT02306928</DOCNO>
	<brief_summary>Antibiotic dose septic shock patient pose challenge clinician due pharmacokinetic change see population . Piperacillin/tazobactam often use empirical treatment , initial appropriate dose crucial reduce mortality . We determine pharmacokinetic profile piperacillin 4g every 8 hour 15 patient treat empirically septic shock . A PK population model establish dual purpose assess current standard treatment simulate alternative dosing regimen modes administration . Time minimal inhibitory concentration ( T &gt; MIC ) predict patient evaluate clinical breakpoint MIC Pseudomonas aeruginosa ( 16 mg/L ) . Pharmacokinetic-pharmacodynamic ( PK-PD ) target evaluate 100 % f T &gt; MIC 50 % fT &gt; 4xMIC .</brief_summary>
	<brief_title>PK Analysis Piperacillin Septic Shock Patients</brief_title>
	<detailed_description>Early appropriate antimicrobial therapy utmost importance reduce mortality critically ill patient sepsis septic shock . Patophysiological change associate septic process , change volume distribution ( Vd ) , drug clearance ( CL ) , decrease plasma-protein concentration organ dysfunction , lead pharmacokinetic ( PK ) change may alter efficacy antimicrobial give . As consequence , antibiotic plasma concentration variable hard predict patient , make optimal antibiotic exposure challenge , especially early phase treatment . In sepctic shock patient , appropriate dose even important , effective antimicrobial therapy within first hour document hypotension associate increase survival hospital discharge . Piperacillin/tazobactam β-lactam - β-lactamase inhibitor combination frequently use empirical treatment critically ill . It time-dependent antibiotic antibacterial activity related time free , unbound concentation drug maintain minimal inhibitory concentration ( f T &gt; MIC ) . Maximizing f T &gt; MIC increase therapeutic impact reduces risk drug resistance development . Because PK change see critically ill , standard dose antimicrobial may result subtherapeutic plasma-concentrations ( 17 ) suggest current empiric dosing recommendation ICU patient inadequate need reconsider ( 18 ) . Patients septic shock especially vulnerable ( 7 ) optimal dose patient crucial reduce mortality . Piperacillin/tazobactam 4g/0.5g every 8 hour ( h ) empiric standard dose sepsis septic shock . The aim study determine dose result therapeutic plasma concentration septic shock patient , within initial 24 hour therapy . A PK population model establish dual purpose assess current standard treatment simulate alternative dosing regimen modes administration . Critically ill patient know suspected septic shock require noradrenaline infusion prescribe piperaillin/tazobactam 4g/0.5g ( Tazocin® ) treat physician eligible study . Patients renal replacement therapy patient age 18 include . Piperacillin/tazobactam 4g/0.5g administer intravenously ( i.v . ) 3 minute every 8 h. Blood sample ( 4 mL ) collect trained staff arterial catheter around time administration third consecutive infusion . Each patient total eight blood sample draw ; administration drug ( time 0 ) , 10 , 20 , 30 minute 1 , 2 , 4 8 h administration drug . The unbound piperacillin plasma concentration determine use ultra high performance liquid chromatography . If bacteria isolate patient , MIC piperacillin obtain use E-tests Mueller-Hinton agar plate . These MICs well clinical MIC breakpoints accord European Committee Antimicrobial Susceptibility Testing ( EUCAST ) Pseudomonas aeruginosa use evaluate follow PK/PD target : 100 % f T &gt; MIC 50 % fT &gt; 4xMIC . There intervention study .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<criteria>Treatment piperacillin/tazobactam le 24 hour . Treatment noradrenaline . Renal replacement therapy . Age 18 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Septic shock</keyword>
	<keyword>Intensive care unit</keyword>
	<keyword>Therapeutic drug monitoring</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Critically ill</keyword>
</DOC>